This NIDA P30 Center supplies the resources needed to apply cutting-edge genomic, proteomic, and bioinformatic technologies to the study of chronic viral infections that are a direct consequence of drug abuse and addiction. Over the past four years, our emphasis has been on hepatitis C virus (HCV) infection and its impact on liver function. In this competitive renewal, we propose to augment our work on HCV with an increased emphasis on AIDS and the intravenous drug abuse population. The Center's unifying theme is to integrate the use of global gene expression and protein profiling technologies to develop a detailed understanding of the host response to virus infection and the molecular mechanisms underlying the progression from chronic HCV infection to end-stage liver disease. To achieve this goal, we have brought together a diverse group of NIH-funded investigators, from basic science and clinical medicine, with combined expertise in virology, immunology, liver disease and transplantation, genomics, proteomics, bioinformatics, biostatistics, and technology development;this includes more than 20 key personnel and over 20 other significant contributors from over a dozen academic institutions and three corporations. This remarkable confluence of basic science and clinical medicine, together with genomic, proteomic, and information technologies, represents an unparalleled opportunity to make advances in our understanding HCV-associated liver disease, AIDS, and HCV/HIV-1 dual infection. The Center consists of three scientific Cores and an Administrative Core, which oversees all aspects of the Center. The Functional Genomics &Virology Core provides the biological samples used for our analyses, which include serial liver biopsies from patients with recurrent HCV after liver transplantation, biopsies from patients with HCV-associated liver disease, and liver biopsies from HCV-infected intravenous drug abusers who are undergoing methadone treatment. AIDS-related studies include the analysis of liver biopsies from patients co-infected with HCV and HIV-1 and from a nonhuman primate model of AIDS. The Proteomics Core is located at Pacific Northwest National Laboratory and provides the Center with world-class mass spectrometry instrumentation and state-of-the-art technology development. The Bioinformatics &Biostatistics Core provides the essential functions of data management, analysis, statistical evaluation, and data sharing and dissemination.

National Institute of Health (NIH)
National Institute on Drug Abuse (NIDA)
Center Core Grants (P30)
Project #
Application #
Study Section
Special Emphasis Panel (ZDA1-RXL-E (02))
Program Officer
Pollock, Jonathan D
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Washington
Schools of Medicine
United States
Zip Code
Britton, Laura-Mae P; Sova, Pavel; Belisle, Sarah et al. (2014) A proteomic glimpse into the initial global epigenetic changes during HIV infection. Proteomics 14:2226-30
Palermo, Robert E; Tisoncik-Go, Jennifer; Korth, Marcus J et al. (2013) Old world monkeys and new age science: the evolution of nonhuman primate systems virology. ILAR J 54:166-80
Chang, Stewart T; Thomas, Matthew J; Sova, Pavel et al. (2013) Next-generation sequencing of small RNAs from HIV-infected cells identifies phased microrna expression patterns and candidate novel microRNAs differentially expressed upon infection. MBio 4:e00549-12
Korth, Marcus J; Tchitchek, Nicolas; Benecke, Arndt G et al. (2013) Systems approaches to influenza-virus host interactions and the pathogenesis of highly virulent and pandemic viruses. Semin Immunol 25:228-39
Selinger, Christian; Katze, Michael G (2013) Mathematical models of viral latency. Curr Opin Virol 3:402-7
Law, G Lynn; Tisoncik-Go, Jennifer; Korth, Marcus J et al. (2013) Drug repurposing: a better approach for infectious disease drug discovery? Curr Opin Immunol 25:588-92
Law, G Lynn; Korth, Marcus J; Benecke, Arndt G et al. (2013) Systems virology: host-directed approaches to viral pathogenesis and drug targeting. Nat Rev Microbiol 11:455-66
Diamond, Deborah L; Krasnoselsky, Alexei L; Burnum, Kristin E et al. (2012) Proteome and computational analyses reveal new insights into the mechanisms of hepatitis C virus-mediated liver disease posttransplantation. Hepatology 56:28-38
McDermott, Jason E; Diamond, Deborah L; Corley, Courtney et al. (2012) Topological analysis of protein co-abundance networks identifies novel host targets important for HCV infection and pathogenesis. BMC Syst Biol 6:28
Rasmussen, Angela L; Tchitchek, Nicolas; Susnow, Nathan J et al. (2012) Early transcriptional programming links progression to hepatitis C virus-induced severe liver disease in transplant patients. Hepatology 56:17-27

Showing the most recent 10 out of 49 publications